IL-1Ra gene transfer potentiates BMP2-mediated bone healing by redirecting osteogenesis toward endochondral ossification
Molecular Therapy · 2023-02 · 31 (2) · 420-434
DOI: 10.1016/j.ymthe.2022.10.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2023-02. Verfasst von Joseph A Panos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA; Musculoskeletal Gene Therapy Research Laboratory, Mayo Clinic, Rochester, M…. Hauptthemen laut MEDLINE: Osteogenesis, Interleukin 1 Receptor Antagonist Protein. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
An estimated 100,000 patients each year in the United States suffer severe disability from bone defects that fail to heal, a condition where bone-regenerative therapies could provide substantial clinical benefits. Although recombinant human bone morphogenetic protein-2 (rhBMP2) is an osteogenic growth factor that is clinically approved for this purpose, it is only effective when used at exceedingly high doses that incur substantial costs, induce severe inflammation, produce adverse side effects, and form morphologically abnormal bone. Using a validated rat femoral segmental defect model, we show that bone formed in response to clinically relevant doses of rhBMP2 is accompanied by elevated expression of interleukin-1 (IL-1). Local delivery of cDNA encoding the IL-1 receptor antagonist (IL-1Ra) achieved bridging of segmental, critical size defects in bone with a 90% lower dose of rhBMP2. Unlike use of high-dose rhBMP2, bone formation in the presence of IL-1Ra occurred via the native process of endochondral ossification, resulting in improved quality without sacrificing the mechanical properties of the regenerated bone. Our results demonstrate that local immunomodulation may permit effective use of growth factors at lower doses to recapitulate more precisely the native biology of healing, leading to higher-quality tissue regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA; Musculoskeletal Gene Therapy Research Laboratory, Mayo Clinic, Rochester, MN, USA; Graduate School of Biomedical Sciences, Mayo Clinic, Rochester…
- Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA; Musculoskeletal Gene Therapy Research Laboratory, Mayo Clinic, Rochester, MN, USA.
- Research Center, Shriners Hospitals for Children, Portland, OR, USA.
- Research Center, Shriners Hospitals for Children, Portland, OR, USA; Department of Orthopedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA.
- Center for Musculoskeletal Disease Research, Departments of Internal Medicine and Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA; Musculoskeletal Gene Therapy Research Laboratory, Mayo Clinic, Rochester, MN, USA; Department of Cell Biology-Inspired Tissue Engineering, MERLN…
Förderung
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Panos, J. A., Coenen, M. J., Nagelli, C. V., McGlinch, E. B., Atasoy-Zeybek, A., De Padilla, C. L., Coghlan, R. F., Johnstone, B., Ferreira, E., Porter, R. M., De la Vega, R. E., & Evans, C. H. (2023). IL-1Ra gene transfer potentiates BMP2-mediated bone healing by redirecting osteogenesis toward endochondral ossification. Molecular Therapy, 31(2), 420-434. https://doi.org/10.1016/j.ymthe.2022.10.007
Vancouver
Panos JA, Coenen MJ, Nagelli CV, McGlinch EB, Atasoy-Zeybek A, De Padilla CL, et al. IL-1Ra gene transfer potentiates BMP2-mediated bone healing by redirecting osteogenesis toward endochondral ossification. Molecular Therapy. 2023;31(2):420-434. doi:10.1016/j.ymthe.2022.10.007
BibTeX
@article{Panos2023,
author = {Panos, Joseph A and Coenen, Michael J and Nagelli, Christopher V and McGlinch, Erin B and Atasoy-Zeybek, Aysegul and De Padilla, Consuelo Lopez and Coghlan, Ryan F and Johnstone, Brian and Ferreira, Elisabeth and Porter, Ryan M and De la Vega, Rodolfo E and Evans, Christopher H},
title = {IL-1Ra gene transfer potentiates BMP2-mediated bone healing by redirecting osteogenesis toward endochondral ossification},
journal = {Molecular Therapy},
year = {2023},
volume = {31},
number = {2},
pages = {420--434},
doi = {10.1016/j.ymthe.2022.10.007}
}
EUVIMED